Abstract:Abstract Background Ceftriaxone, a third-generation cephalosporin antibiotic with a long plasma half-life, is widely used to treat various infections. The use of ceftriaxone can sometimes induce biliary sludge or stone formation. Although most cases of ceftriaxone-induced pseudolithiasis are asymptomatic or mild and resolve with discontinuation of the drug, we experienced an elderly case of severe acute necrotizing calculous cholecystitis after administration of ceftriaxone. Case presentation A 72-year-old male patient was admitted to our hospital because of acute diverticulitis in ascending colon. Ceftriaxone was administered at a dose of 2 g/day for 6 days. Although he recovered after therapy, he was readmitted about 2 weeks later because of severe pain with rebound tenderness in the right upper quadrant. An abdominal imaging study revealed stones and sludge in the gallbladder that were not observed before starting ceftriaxone therapy. Therefore, antibiotic treatment with flomoxef 2 g/day was indicated. However, on the fifth day of readmission, the peritoneal irritation symptoms in the right upper quadrant worsened, and elevated inflammatory response and liver dysfunction were observed. Cholecystectomy was performed based on these findings. The resected inflamed gallbladder showed acute necrotizing cholecystitis with sand granular gallstones. A comparative analysis of the infrared spectroscopic pattern of the composition of gallstones collected during surgery with that of the ceftriaxone powder revealed that both have very similar infrared spectroscopic patterns. Conclusions Ceftriaxone-related pseudolithiasis is generally reversible and mainly observed in children. Here, we report a rare case of ceftriaxone-related acute necrotizing cholecystitis in an elderly patient. We confirmed that the stones in the gallbladder are composed of ceftriaxone. The older age, dehydration, fasting, and long-time bed rest during the administration of high-dose ceftriaxone were the potential risk factors for gallstone formation.

S4448 The Case of Life-Threatening Hepatitis: Ceftriaxone-Induced Severe Liver Injury

Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature

A Case-Report of Drug-Induced Mixed Liver Injury Resulting From Cefepime Exposure

Ceftriaxone-induced severe hemolytic anemia, renal calculi, and cholecystolithiasis in a 3-year-old child: a case report and literature review

Acute necrotizing calculous cholecystitis after treatment with ceftriaxone in an elderly patient: a case report

Ceftriaxone-Induced Hemolytic Anemia in a Jehovah's Witness

Ceftriaxone-induced symptomatic cholelithiasis in a child: case report and literature review

An Uncommon Incidence of Drug-Induced Immune Hemolytic Anemia Secondary to Ceftriaxone

Ceftriaxone-Induced Hemolytic Anemia: A Rare Case Report

Acute liver failure caused by high-dose tigecycline: A case report

Clinical and biochemical characteristics, and outcome in 33 patients with ceftriaxone-induced liver injury

Drugs, Bugs or Cancer? A Case of Cholestatic Hepatitis

S4482 Piperacillin-Tazobactam and Hepatic Complications: A Case Report on Drug-Induced Liver Injury

S4547 Severe Immune Checkpoint Inhibitor Hepatitis: Case Report

Severe drug-induced immune hemolysis due to ceftriaxone

[Ceftriaxone-induced immune haemolytic anaemia and multi-organ failure]

Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia

Clinical Conundrum of Acute Hepatitis B With Concurrent Hepatitis E Infection Leading to Severe Acute Liver Injury

Ceftriaxone-Induced Encephalopathy in a Patient With Chronic Kidney Disease

Brief Communication: Severe Hepatotoxicity of Telithromycin: Three Case Reports and Literature Review

Severe drug-induced immune hemolytic anemia due to cefmetazole: A case report